GENIX
Price
$16.80
Change
+$0.28 (+1.69%)
Updated
Jun 15 closing price
Net Assets
485.07M
VIMSX
Price
$88.24
Change
+$1.08 (+1.24%)
Updated
Jun 15 closing price
Net Assets
218.84B
Interact to see
Advertisement

GENIX vs VIMSX

Header iconGENIX vs VIMSX Comparison
Open Charts GENIX vs VIMSXBanner chart's image
GENIX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
GENIX vs. VIMSX commentary
Jun 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENIX is a Hold and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 219B vs. GENIX (485M). VIMSX pays higher dividends than GENIX: VIMSX (1.25) vs GENIX (0.00). GENIX was incepted earlier than VIMSX: GENIX (13 years) vs VIMSX (28 years). GENIX (1.72) is less costly to investors than VIMSX (0.17). GENIX is a more actively managed with annual turnover of: 466.00 vs. VIMSX (16.00). VIMSX has a lower initial minimum investment than GENIX: VIMSX (3000) vs GENIX (100000). GENIX annual gain was more profitable for investors over the last year : 26.01 vs. VIMSX (17.89). VIMSX return over 5 years is better than : 37.23 vs. GENIX (31.42).
GENIXVIMSXGENIX / VIMSX
Total Expense Ratio1.510.17888%
Annual Report Gross Expense Ratio1.720.171,012%
Fund Existence13 years28 years-
Gain YTD12.61110.050125%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets485M219B0%
Annual Yield % from dividends0.001.25-
Returns for 1 year26.0117.89145%
Returns for 3 years46.1947.5497%
Returns for 5 years31.4237.2384%
Returns for 10 years46.41165.4928%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDUC1.400.05
+3.70%
Educational Development Corp
ALHC19.780.03
+0.15%
Alignment Healthcare
BBDO3.00-0.02
-0.66%
Banco Bradesco SA
NBP1.47-0.02
-1.34%
NovaBridge Biosciences
AMPH19.71-0.38
-1.89%
Amphastar Pharmaceuticals